164 related articles for article (PubMed ID: 30945953)
1. The 12-month follow-up of the low-intensity extracorporeal shockwave therapy in the treatment of patients with chronic pelvic pain syndrome refractory to 3-As medications.
Guu SJ; Liu CC; Juan YS; Li CC; Tsai CC
Aging Male; 2020 Dec; 23(5):793-800. PubMed ID: 30945953
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Low-Intensity Extracorporeal Shock Wave Therapy on Men With Chronic Pelvic Pain Syndrome Refractory to 3-As Therapy.
Guu SJ; Geng JH; Chao IT; Lin HT; Lee YC; Juan YS; Liu CC; Wang CJ; Tsai CC
Am J Mens Health; 2018 Mar; 12(2):441-452. PubMed ID: 29072124
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy and safety of extracorporeal shock wave therapy (Li-ESWT) protocols in the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) patients.
Sokmen D; Comez YI
Aging Male; 2023 Dec; 26(1):2253876. PubMed ID: 37671978
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of low-intensity extracorporeal shock wave therapy for the treatment of chronic prostatitis/chronic pelvic pain syndrome: A systematic review and meta-analysis.
Yuan P; Ma D; Zhang Y; Gao X; Liu Z; Li R; Wang T; Wang S; Liu J; Liu X
Neurourol Urodyn; 2019 Aug; 38(6):1457-1466. PubMed ID: 31037757
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Low-Intensity Extracorporeal Shock Wave Therapy for the Treatment of Chronic Pelvic Pain Syndrome IIIb: A Prospective-Randomized, Double-Blind, Placebo-Controlled Study.
Kim KS; Choi YS; Bae WJ; Cho HJ; Ha US; Hong SH; Lee JY; Ahn ST; Moon DG; Kim SW
World J Mens Health; 2022 Jul; 40(3):473-480. PubMed ID: 34448374
[TBL] [Abstract][Full Text] [Related]
6. Dietary habits and lifestyle related to the effectiveness of low-intensity extracorporeal shock wave therapy for chronic prostatitis/chronic pelvic pain syndrome-like symptoms: Initial results.
Bian Z; Jin C; Mo F; Zhang S; Meng J; Zhang M; Zhang L; Chen X; Hao Z; Song Z; Liang C
Andrologia; 2022 Oct; 54(9):e14490. PubMed ID: 35671994
[TBL] [Abstract][Full Text] [Related]
7. Outcomes and clinical predictors of extracorporeal shock wave therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome: a prospective randomized double-blind placebo-controlled clinical trial.
Sakr AM; Fawzi AM; Kamel M; Ali MM
Prostate Cancer Prostatic Dis; 2022 Mar; 25(1):93-99. PubMed ID: 34635804
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Extracorporeal Shock Wave Therapy in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Acquired Premature Ejaculation Patients.
Sokmen D; Comez YI
Urol Int; 2023; 107(9):872-876. PubMed ID: 37611558
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of low-intensity extracorporeal shock wave treatment combined with or without medications in Chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis.
Kong X; Hu W; Dong Z; Tian J; Wang Y; Jin C; Liang C; Hao Z; Wang Z
Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):483-494. PubMed ID: 35798855
[TBL] [Abstract][Full Text] [Related]
10. The Efficacy and Safety of Extracorporeal Shockwave Therapy versus Acupuncture in the Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Evidence Based on a Network Meta-analysis.
Kang Y; Song P; Cao D; Di X; Lu Y; Liu P; Dong Q
Am J Mens Health; 2021; 15(6):15579883211057998. PubMed ID: 34911370
[TBL] [Abstract][Full Text] [Related]
11. Low-Intensity Extracorporeal Shockwave Therapy Can Improve Erectile Function in Patients Who Failed to Respond to Phosphodiesterase Type 5 Inhibitors.
Tsai CC; Wang CJ; Lee YC; Kuo YT; Lin HH; Li CC; Wu WJ; Liu CC
Am J Mens Health; 2017 Nov; 11(6):1781-1790. PubMed ID: 28884638
[TBL] [Abstract][Full Text] [Related]
12. Low-intensity extracorporeal shock wave therapy for male chronic pelvic pain syndrome: a systematic review and meta-analysis.
Li G; Man L
Transl Androl Urol; 2021 Mar; 10(3):1202-1211. PubMed ID: 33850755
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal Shockwave Therapy Combined with Drug Therapy in Chronic Pelvic Pain Syndrome : A Randomized Clinical Trial.
Rayegani SM; Razzaghi MR; Raeissadat SA; Allameh F; Eliaspour D; Abedi AR; Javadi A; Rahavian AH
Urol J; 2020 Mar; 17(2):185-191. PubMed ID: 31004340
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Different Treatment Regimens of Extracorporeal Shockwave Therapy in Chronic Low-back Pain: A Randomized Controlled Trial.
Sun H; Chen H; Mu G; Fu H; Yue L
Pain Physician; 2022 Nov; 25(8):E1211-E1218. PubMed ID: 36375191
[TBL] [Abstract][Full Text] [Related]
15. Low intensity extracorporeal shockwave therapy for chronic pelvic pain syndrome patients with erectile dysfunction.
Daneshwar D; Nordin A
Medicine (Baltimore); 2022 Jan; 101(2):e28546. PubMed ID: 35029213
[TBL] [Abstract][Full Text] [Related]
16. Li-ESWT treatment reduces inflammation, oxidative stress, and pain via the PI3K/AKT/FOXO1 pathway in autoimmune prostatitis rat models.
Feng B; Dong Z; Wang Y; Yan G; Yang E; Cheng H; Liang C; Hao Z; Zhang X; Song Z; Jiang Z; Chen M; Yue Z; Wang Z
Andrology; 2021 Sep; 9(5):1593-1602. PubMed ID: 33960707
[TBL] [Abstract][Full Text] [Related]
17. Long term efficacy of extracorporeal shock wave therapy [ESWT] for treatment of refractory chronic abacterial prostatitis.
Al Edwan GM; Muheilan MM; Atta ON
Ann Med Surg (Lond); 2017 Feb; 14():12-17. PubMed ID: 28119778
[TBL] [Abstract][Full Text] [Related]
18. Low-intensity extracorporeal shock wave therapy for III B chronic pelvic pain syndrome.
Li G; Man L
Transl Androl Urol; 2020 Jun; 9(3):1323-1328. PubMed ID: 32676416
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Radial Extracorporeal Shock Wave Therapy for Chronic Pelvic Pain Syndrome: A Nonrandomized Controlled Trial.
Zhang ZX; Zhang D; Yu XT; Ma YW
Am J Mens Health; 2019; 13(1):1557988318814663. PubMed ID: 30486723
[TBL] [Abstract][Full Text] [Related]
20. Comparing two different low-intensity shockwave therapy frequency protocols for nonbacterial chronic prostatitis/chronic pelvic pain syndrome: A two-arm, parallel-group randomized controlled trial.
Mykoniatis I; Pyrgidis N; Kalyvianakis D; Zilotis F; Kapoteli P; Fournaraki A; Hatzichristou D
Prostate; 2021 Jun; 81(9):499-507. PubMed ID: 33929052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
